163 related articles for article (PubMed ID: 3590116)
1. Interrelationship of protamine and platelet factor 4 in the neutralization of heparin.
Shanberge JN; Quattrociocchi-Longe TM; Martens MH
Thromb Res; 1987 Apr; 46(1):89-100. PubMed ID: 3590116
[TBL] [Abstract][Full Text] [Related]
2. Influence of platelet factor 4 on the neutralization of heparin by protamine.
Shanberge JN; Quattrociocchi-Longe TM
Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
[TBL] [Abstract][Full Text] [Related]
3. Heparin neutralization by recombinant platelet factor 4 and protamine.
Levy JH; Cormack JG; Morales A
Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278
[TBL] [Abstract][Full Text] [Related]
4. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
Poon MC; Hurst RE; Rives MS
Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.
Sasaki E; Minamiguchi K; Kitazato KT; Nagase H; Kitazato K
Haemostasis; 1997; 27(4):174-83. PubMed ID: 9483172
[TBL] [Abstract][Full Text] [Related]
6. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
Bode AP; Castellani WJ; Hodges ED; Yelverton S
Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
[TBL] [Abstract][Full Text] [Related]
7. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
Cook JJ; Niewiarowski S; Yan Z; Schaffer L; Lu W; Stewart GJ; Mosser DM; Myers JA; Maione TE
Circulation; 1992 Mar; 85(3):1102-9. PubMed ID: 1537108
[TBL] [Abstract][Full Text] [Related]
9. Human platelet factor 4 and protamine sulphate interaction with glycosaminoglycans in the rabbit.
Cella G; Myers CJ; Prosdocimi M; Sasahara AA
Eur J Clin Invest; 1987 Dec; 17(6):548-54. PubMed ID: 3123254
[TBL] [Abstract][Full Text] [Related]
10. The effect of platelet factor 4 (PF4) on assays of plasma heparin.
Levine SP; Sorenson RR; Harris MA; Knieriem LK
Br J Haematol; 1984 Aug; 57(4):585-96. PubMed ID: 6743573
[TBL] [Abstract][Full Text] [Related]
11. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass.
Bernabei A; Gikakis N; Maione TE; Kowalska MA; Yan Z; Niewiarowski S; Edmunds LH
J Thorac Cardiovasc Surg; 1995 Apr; 109(4):765-71. PubMed ID: 7715225
[TBL] [Abstract][Full Text] [Related]
12. Effect of protamine sulfate on antithrombin III activity.
Matsuo T; Shanberge JN; Matsuo O
Clin Chim Acta; 1983 Jul; 131(3):233-8. PubMed ID: 6883717
[TBL] [Abstract][Full Text] [Related]
13. Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures.
Shanberge JN; Murato M; Quattrociocchi-Longe T; van Neste L
Am J Clin Pathol; 1987 Feb; 87(2):210-7. PubMed ID: 3812352
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Fiore MM; Mackie IM
Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of recombinant platelet factor 4 and protamine sulfate for heparin neutralization: clotting and clearance studies in rat.
Korutla LN; Stewart GJ; Lasz EC; Maione TE; Niewiarowski S
Thromb Haemost; 1994 May; 71(5):609-14. PubMed ID: 8091389
[TBL] [Abstract][Full Text] [Related]
16. Recombinant platelet factor 4 reversal of heparin in human cardiopulmonary bypass blood.
Williams RD; D'Ambra MN; Maione TE; Lynch KE; Keene DF
J Thorac Cardiovasc Surg; 1994 Nov; 108(5):975-83. PubMed ID: 7967683
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation following heparin and protamine administration.
Ellison N; Edmunds LH; Colman RW
Anesthesiology; 1978 Jan; 48(1):65-8. PubMed ID: 619707
[TBL] [Abstract][Full Text] [Related]
18. Does protamine chloride neutralize low molecular weight heparin sufficiently?
Gram J; Mercker S; Bruhn HD
Thromb Res; 1988 Dec; 52(5):353-9. PubMed ID: 2851882
[TBL] [Abstract][Full Text] [Related]
19. Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine.
Mouton C; Calderon J; Janvier G; Vergnes MC
Thromb Res; 2003; 111(4-5):273-9. PubMed ID: 14693175
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin.
Eslin DE; Zhang C; Samuels KJ; Rauova L; Zhai L; Niewiarowski S; Cines DB; Poncz M; Kowalska MA
Blood; 2004 Nov; 104(10):3173-80. PubMed ID: 14764524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
